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Thank you, Evan and the Awards Committee, for choosing
me to receive this honor.
I confess that before I learned of this award, I hadn’t
known much about Curt Stern, but when I ﬁnally read
some of his work in preparation for this lecture, it really
struck a chord. In an essay he published in 1944, entitled
“The Journey, Not the Goal,”1 Stern addressed the dilemma
we often face between the desire to direct our research
toward an altruistic goal, like understanding human dis-
ease, and the pure joy of exploration and discovery, which
sometimes diverts from the goals that we set out after.
Stern’s essay makes a strong case for the value and im-
portance of exploration for the sheer joy of it—that the
little crooked paths taken by scientists who stray from the
main road can unexpectedly turn into major highways.
And how appropriate, because the research that brought
me here today began by wandering, and the tendency to
wander off from my original goals has been a recurring
and vaguely embarrassing feature of my scientiﬁc person-
ality, but now I guess I can own up to it.
I wandered onto this particular crooked path in the fall
of 1989. Everyone in my lab was then working on a great
research problem—trying to understand the molecular
events between entry of a retrovirus into a host cell and
integration of the viral genome into the host’s genome.2
It was fun and challenging, and we had a very clear and
unquestionably important practical goal—to try to under-
stand enough about the basic molecular mechanisms so
that we could eventually ﬁnd ways to block HIV from
infecting human cells.
But, as we all do, I liked to read about interesting prob-
lems far from my own research and to daydream about
what I might do if I were working on them. One day, I
happened upon an article about imprinting and its poten-
tial role in human genetic diseases.3 At the time, there was
only a handful of imprinted genes known, so it started
me thinking about how I might ﬁnd them all systemati-
cally. As a DNA enzymologist, the rather cockamamie
scheme I dreamed up involved reciprocal crosses of two
divergent strains of mice, a series of hybridizations of
cDNAs, and the use of mismatch-repair enzymes to se-
lectively isolate perfectly base-paired duplexes, eventu-
ally yielding a pool of sequences representing just the im-
printed genes.
It was a pretty far-fetched idea, and I might have just
chalked it up as the usual scientiﬁc daydreaming and for-
gotten about it, but, once I had a basic biochemical strat-
egy worked out in principle, I encountered a set of great
papers by Neil Risch, last year’s Stern award recipient, about
mapping complex traits by using affected relative pairs
and mapping where in the genome they shared identity
by descent.4–6
It occurred to me that the same basic biochemicalmeth-
ods could be used as an efﬁcient way to get a high-reso-
lution genomewide map of all the sequences identical by
descent between two genomes, which, 16 years ago, seemed
a useful contribution to linkage or association mapping.
The ﬁnal step in such a procedure, as I envisioned it,would
involve a hybridization step analogous to FISH, but using
a more organized version of a metaphase spread, in which
cloned segments of the genome were laid out in a grid on
a glass slide, so that we could read out a high-resolution
map of identity by descent.
The challenge of making this wild scheme work and of
taking on some really great mysteries in human genetics
was irresistible. I was soon joined on this project by Stan
Nelson, and, in a couple of years, the method, which we
called “genomic mismatch scanning,” was working, as Stan
demonstrated using yeast as a model.7
The experiment was to map, for each of the haploid
offspring of a cross between these two yeast strains, which
genetic intervals were identical to each of the two parents,
using our biochemical procedure to separately purify the
sequences identical to the each parent and then hybridize
each selected pool of DNA to an array of clones on a ﬁlter
to produce the map.
With the basic procedure worked out, our next major
tasks would be to get the same method to work on the
human genome; to miniaturize the array, so that the re-
agent and production costs and handling properties of the
arrays representing a large genome like the human genome
would be manageable; and to use two-color comparative
ﬂuorescence to make the results robust and quantitative.
I had a 2-year pilot grant from National Center for Hu-
man Genome Research (NCHGR) to fund the initial work,
so I wrote a renewal application in which I proposed to
adapt it to the human genome and to develop the DNA
microarray technology. Since we were fresh from our suc-
cess in developing this new mapping method, I thought
this grant would be a sure thing. When I got the reviews,
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Figure 1. First result with a whole-genome DNA microarray: ge-
notyping a Saccharomyces cerevisiae isolate by genomic mismatch
scanning (experiment performed by J. DeRisi).
I was devastated—the grant got the worst priority score I
had ever seen. The reviewers liked the idea of adapting
our biochemical procedure to the human genome, but
they singled out the microarray proposal as unnecessary,
premature, and very impractical.
Despite this terrible review, the folks at NCHGR were
kind enough to give me a little bridge funding to keep the
project alive and advised me to resubmit a proposal fo-
cusing on just the biochemistry and to get rid of the spe-
ciﬁc aim to develop DNA microarrays. So I grudgingly sub-
mitted that eviscerated proposal, and, this time, I got the
grant.
But, meanwhile, we “blasted ahead” with the work on
DNA microarrays, thanks to a smart, ambitious engineer-
ing student, Dari Shalon, and in a year—by the time that
grant was funded—we had a simple system working for
making and using DNA microarrays.8
At ﬁrst, I thought that using DNA microarrays to look
at global gene expression was just going to be a fun side
project and that the more important and exciting appli-
cation was for large-scale genotyping. So, when Joe Derisi
joined my lab and printed the ﬁrst microarrays repre-
senting the complete yeast genome, his very ﬁrst hybrid-
ization was to get a genomewide genotype using genomic-
mismatch scanning (ﬁg. 1). It was a really beautiful result,
one of the most exciting pictures I had ever seen. The red
spots represent the genes inherited from one parent, the
green spots genes inherited from the other parent.
With four microarray hybridizations, we were able to
determine the complete high-resolution genotypes of all
four haploid products of a single yeast meiosis at single-
gene resolution. It looked as if we were well on our way
toward our goal; yet, almost 10 years later, we still haven’t
published this work. So why did we wander off the trail
again?
The core idea of genetics is that variation in traits can
be linked to variation in genes. We’re used to thinking of
this principle as it applies to the links between variation
in gene sequences and variation between whole individ-
uals. But there’s a much richer kind of variation in both
genes and traits inside each of our bodies, and, in many
ways, it’s more accessible to study. Although the cells that
make up our bodies each have an identical set of genes,
they are astonishingly diverse in shape and size and be-
havior. That’s possible because they are equally diverse in
the patterns in which their genes are expressed—just as
we can use the 30,000 or so words in our vocabulary to
write a million different stories by combining them in
different patterns. Our cells can use the 30,000 or so genes
in their genetic vocabulary in different and dynamically
changing patterns in each cell to specify the unique and
dynamic characteristics of that cell.
What made us wander again off the path we had started
on was that some of the earliest experiments carried out
by Joe DeRisi, Mike Eisen, and Vishy Iyer showed that, by
using DNA microarrays to look systematically at the pat-
terns of mRNA expression in diverse cells and tissues, we
could make a map that shows relationships between ex-
pression of speciﬁc sets of genes and the distinctive char-
acteristics of each human cell or tissue.9–11
We could apply the fundamental logic of genetics to
this new kind of data, to make a new kind of map of the
genome that shows connections between traits—of cells,
tissues, or individuals—and genes—in this case, not their
sequence but their expression—on a genomewide scale.10
In this new kind of map, the genes could be ordered, not
by their chromosomal location, but by their pattern of
expression, and, thus, indirectly by the biological role that
pattern represents. And cells, tissues, physiological or de-
velopmental processes, or individuals could also be clus-
tered or grouped on the basis of the similarities in their
global expression patterns, which are closely tied to their
phenotypic characteristics.
Relating the patterns of expression of speciﬁc genes to
phenotypic variation gives us a way to learn about the
functions of speciﬁc genes. Conversely, the gene-expres-
sion proﬁle of a human cell or tissue can be a distinctive
identifying signature—analogous to the genotype—of that
tissue.12 And that has obvious medical implications.13
Soon after we had the microarray technology in place,
I began a very rewarding collaboration with David Bot-
stein to proﬁle gene-expression patterns in cancer.14–18 Fig-
ure 2 shows some of our earliest data from several different
kinds of common human cancers.
You can certainly tell apart cancers that we already knew
were different—for example, the gene-expression patterns
in the breast cancers (black box) are clearly very different
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Figure 2. Analysis of gene-expression patterns in human cancer. This “map” shows the results of quantitative proﬁling of gene-
expression patterns in a diverse panel of human cancers in a table format in which each row represents a speciﬁc gene, each column
represents a speciﬁc tumor sample, and the measured abundance of each gene’s transcript in each tumor is represented by a color scale
in which bright yellow represents the highest expression levels and dark blue represents the lowest expression levels. The genes and
tumor samples are organized by hierarchical clustering on the basis of similarity in their overall patterns of expression. Note that tumors
of similar histological type—for example, breast cancer (black box) and prostate cancer (red box)—almost always cluster together, yet
tumors of the same histological type can vary signiﬁcantly in their expression patterns.
from the patterns in the prostate cancers (red box). And
the fact that these molecular portraits give us a richly de-
tailed picture of what proteins are present and which
regulatory systems appear abnormally active or missing
in each of these tumors becomes more and more im-
portant as drugs that act on speciﬁc molecular targets
become available.
And, if you look more closely, you can see that, even
within a single diagnostic classiﬁcation—for example,
among the breast cancers—there is actually tremendous
molecular diversity: each individual patient’s cancer has
a distinctive expression pattern.15,16 These differences in
gene-expression patterns among cancers that we can’t tell
apart just by looking under the microscope turn out to
provide valuable new information about their potential
to progress and metastasize—in many cases, much better
than the classic pathological predictors.
Of course, we don’t want just diagnostic markers. We
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really want to understand the underlying mechanisms of
pathogenesis, and, in fact, our current work using DNA
microarrays to investigate cancer focuses almost entirely
on working out the pathogenetic mechanisms that un-
derlie speciﬁc features of the gene-expression patterns we
see in speciﬁc cancers.
Maps like these show us a huge number of possible con-
nections between the distinctive characteristics of each
cancer and the speciﬁc genes it expresses, but making
sense of the connections depends on synthesis of what
we know about this cancer on the one hand—bits of in-
formation contained in thousands of published articles—
and what we know about these genes on the other, again
information locked away in thousands of published arti-
cles. When my colleagues and I started trying to make
sense of maps like these, we immediately discovered that
we couldn’t read all these thousands of articles fast enough
to realize the potential emergent value of large, systematic
data sets like this—we would need to develop software
tools to collect and synthesize this information. But there
was a terrible, fundamental problem that completely
blocked the way to this goal—the way that published sci-
entiﬁc information is managed. The published knowledge
that we wanted to integrate was not available to be used
in that way for a simple and perverse reason: the tradi-
tional scientiﬁc publishers consider the work we scientists
have carried out and published in their journals to be their
private property and won’t allow the information to leave
their control so that it can be used creatively for the good
of science and the public.
The fact that the world’s treasury of published DNA se-
quences is a shared public resource, available to be down-
loaded in their entirety into individual researcher’s com-
puters and used and analyzed without restriction, was the
secret to the success of the Human Genome Project and
much of modern biology, is so obviously the right thing
for science that we take it for granted.19 And that’s the
way it can be and ought to be, not just for sequences but
for all the work that we publish.
That realization has led me to another winding trail, on
which I’ve been joined by my former mentor, Harold Var-
mus, and former post-doc, Mike Eisen: the Public Library
of Science, whichwe started as a grass-roots advocacymove-
ment and which has turned into a nonproﬁt, open-access
publisher of great scientiﬁc journals, including PLoS Ge-
netics, PLoS Biology, and PLoS Medicine.20
Our goal is not just to publish our own open-access
journals but to catalyze a change in the whole system, so
that every published scientiﬁc article and all its contents
become a public resource, freely available to be read or
used in any way by anyone in the world, just as published
DNA sequences are today.
Sixteen years ago, I was determined to ﬁgure out HIV
replication, but I wandered far off the trail. My graduate
advisor, Nick Cozzarelli, whose insight andwisdom I appre-
ciate more with each passing year, once chided me about
a paper I was neglecting to write by saying that I got too
much joy from initiating projects and not enough joy from
completing them. It was a pretty apt criticism. But I console
myself with the closing words of this essay by my kindred
spirit, Curt Stern: “the joy of the journey is never ending,
that of reaching a goal always passing.”1(p100)
The accomplishments that the Curt Stern Award rec-
ognizes depend on ideas and discoveries and contribu-
tions from a wonderful, brilliant group of students and
post-docs and colleagues. It’s been my great privilege and
good fortune to know them and work with them.
Web Resource
The URL for data presented herein is as follows:
Public Library of Science, http://www.plos.org/
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